Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-01-15 @ 9:06 PM
Study NCT ID:
NCT05457933
Status:
COMPLETED
Last Update Posted:
2023-10-19
First Post:
2022-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Sponsor:
Medanta, The Medicity, India
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-05
First Submit QC Date:
None
Study First Post Date:
2022-07-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-18
Last Update Post Date:
2023-10-19
Last Update Post Date Type:
ACTUAL